An Expert View from Philip Breesch, executive vice president of the CARE Franchise, Chiesi Group. Last year, the neonatal ...

US biotech Arvinas and its partner Pfizer on Friday announced that the US Food and Drug Administration (FDA) has granted ...

Hemab Therapeutics Holdings, a Phase III-ready biotech developing blood coagulation disorder treatments, has announced terms ...

Cambridge, USA-based biotech Moderna today reported financial results and provided business updates for the first quarter of ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today approved  GSK's Lynavoy (linerixibat) for use to ...

US biotech Alector has discontinued development of its Alzheimer’s disease candidate nivisnebart after an interim analysis ...

Over 500 new drugs are expected to be introduced to the Russian market this year, including through localization, according ...

USA-based Pinnaql has acquired Pharma Resource Group (PRG), a provider of analytical sciences, formulation, scientific ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Aspaveli (pegcetacoplan) to treat patients ...

US biotech major Amgen late yesterday announced financial results for the first quarter of 2026, showing that revenues ...

US biotech Cue Biopharma has set out a three-part reset, appointing Shao-Lee Lin as chief executive, licensing a ...

US biotech Axsome Therapeutics (Nasdaq: AXSM) has secured US regulator approval for Auvelity (dextromethorphan hydrobromide ...